
SS-31 10mg
SS-31 10mg is for research purposes only. Search Hoyl2509020007 for COA.
Automatic discounts will apply at check out: Buy 5 get 1 more for free, 10 gets 3 more for free, 15 gets 5 more, 20 gets 7. Place the total number you want in cart & the discounts will be automatic, This discount is combinable with free shipping, but not other discounts.
It is crucial to understand that SS-31 is an investigational drug that has not been approved by the FDA for human use. The long-term safety of the substance is not yet established in humans, as studies have not been conducted for treatments longer than four weeks.
Commonly Reported Side Effects (mostly mild)
-
Injection Site Reactions: These are the most common adverse events and can include redness (erythema), itching (pruritus), pain, and irritation.
-
Headaches: Mild to moderate headaches have been reported.
-
Gastrointestinal Issues: Abdominal pain and flatulence have been noted.
-
Dizziness and Nausea: Some individuals have experienced dizziness.
-
Fatigue: Mild fatigue has been reported during treatment.
Potential for Serious Side Effects (rare)
-
While rare, more serious symptoms have been reported in clinical studies, including:
-
Serious heart symptoms, such as a fast or pounding heartbeat, fluttering in the chest, shortness of breath, and/or sudden dizziness.
-
Severe headaches.
-
Confusion and slurred speech.
-
Severe weakness.
-
Other Potential Risks
-
Uncertainty for specific populations: There is no information available on the safety and efficacy of SS-31 use in pregnant or breastfeeding women.
-
Lack of long-term data: Since treatments longer than four weeks have not been studied in humans, the long-term safety of SS-31 is unknown.
-
Investigational status: The substance is intended for use by medical professionals for non-clinical, non-consumable purposes. It is not approved for use in humans and its safety has not been fully validated through rigorous clinical trials for all potential uses.